Feb 25, 2020
Huntsman Cancer Institute Translational Scholars: Courtney Scaife, MD
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a Huntsman Translational Scholar award.
Feb 07, 2020
New CAR-T Target Yields Promising Results for Multiple Myeloma
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.
Jan 13, 2020
Huntsman Cancer Institute Translational Scholars: Randy Jensen, MD, PhD
Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with a Huntsman Translational Scholar award.
Sep 30, 2019
International Lifetime Achievement Award in Leukemia Research Awarded to Michael Deininger, MD, PhD
The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD. Deininger’s selection as the 2019 awardee was announced in February. Formal presentation of the prize occurred at an international scientific conference in Bordeaux, France, earlier this month.
Jun 19, 2019
Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients
Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.
Jun 06, 2019
Caring for Patients with a Family History of Pancreatic Cancer
Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.
May 31, 2019
International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results
Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.
May 13, 2019
New Insights into Treatment Targets for Men with Advanced Prostate Cancers
In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies